लोड हो रहा है...
Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2
Medical treatment has progressed significantly over the past decade towards achieving and maintaining clinical remission in patients with refractory ulcerative colitis (UC). Proposed mediators of inflammation in UC include pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interl...
में बचाया:
| में प्रकाशित: | World J Gastroenterol |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Baishideng Publishing Group Inc
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4528020/ https://ncbi.nlm.nih.gov/pubmed/26269667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i29.8776 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|